Evidence map›Paper›PMID 40712149›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

RAB5A Promotes Active Fluid Wetting by Reprogramming Breast Cancer Spheroid Mechanics.

Grégoire Lemahieu, Paulina Moreno-Layseca, Tobias Hub, Carlo Bevilacqua, Manuel Gómez-González, Federica Pennarola, Federico Colombo, Andrew E Massey, Leonardo Barzaghi, Andrea Palamidessi and 10 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. What is active wetting?The European physical journal. E, Soft matter · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Beyond the membrane: rethinking EGFR signaling in physiology and cancer.Cellular and molecular life sciences : CMLS · 2026
    Review
  7. RAB5A Promotes Active Fluid Wetting by Reprogramming Breast Cancer Spheroid Mechanics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Grégoire LemahieuDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.ORCID https://orcid.org/0009-0007-8647-1653
Paulina Moreno-LaysecaTurku Bioscience Center, University of Turku, Åbo Akademi University, Tykistökatu 6, Turku, 20520, Finland.
Tobias HubDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.
Carlo BevilacquaCell Biology, Biophysics, European Molecular Biology Laboratory (EMBL), Meyerhofstraße 1, 69117, Heidelberg, Germany.
Manuel Gómez-GonzálezInstitute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science, Technology (BIST), C/ Baldiri Reixac 10-12, Barcelona, 08028, Spain.
Federica PennarolaDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.
Federico ColomboInstitute for Molecular Systems Engineering, Advanced Materials (IMSEAM), Heidelberg University, 69120, Heidelberg, Germany.
Andrew E MasseySection on Mechanobiology, National Institute of Biomedical Imaging, Bioengineering, National Institutes of Health South Drive 50, Bethesda, MD, 20892, USA.
Leonardo BarzaghiMechanisms of Tumor Cell Migration, IFOM ETS - The AIRC Institute of Molecular Oncology, Via Adamello 16, Milan, 20139, Italy.
Andrea PalamidessiMechanisms of Tumor Cell Migration, IFOM ETS - The AIRC Institute of Molecular Oncology, Via Adamello 16, Milan, 20139, Italy.
Leon-Luca HomagkDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.
Samuel F H BarnettDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.
Alexander X Cartagena-RiveraSection on Mechanobiology, National Institute of Biomedical Imaging, Bioengineering, National Institutes of Health South Drive 50, Bethesda, MD, 20892, USA.
Christine Selhuber-UnkelInstitute for Molecular Systems Engineering, Advanced Materials (IMSEAM), Heidelberg University, 69120, Heidelberg, Germany.
Robert PrevedelCell Biology, Biophysics, European Molecular Biology Laboratory (EMBL), Meyerhofstraße 1, 69117, Heidelberg, Germany.
Xavier TrepatInstitute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science, Technology (BIST), C/ Baldiri Reixac 10-12, Barcelona, 08028, Spain.
Joachim P SpatzDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.
Johanna IvaskaTurku Bioscience Center, University of Turku, Åbo Akademi University, Tykistökatu 6, Turku, 20520, Finland.
Giorgio ScitaMechanisms of Tumor Cell Migration, IFOM ETS - The AIRC Institute of Molecular Oncology, Via Adamello 16, Milan, 20139, Italy.
Elisabetta Ada Cavalcanti-AdamDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.ORCID https://orcid.org/0000-0003-0243-1552

Funding

Bavarian High-Tech Agenda ProgramCancer Foundation FinlandCentre of Excellence program 346131ERC Consolidator Grant Brillouin4Life 864027ERC Consolidator Grant PHOTOMECH 101001797European Molecular Biology Laboratory (EMBL)European Research Council Adv-883739Finnish Cancer InstituteGeneralitat de Catalunya AGAUR SGR-2017-01602German Center for Lung Research (DZL)German Research Foundation via the Excellence Cluster 3D Matter Made to Order EXC-2082/1-390761711Jane and Aatos Erkko Foundation'la Caixa' Foundation LCF/PR/HR20/52400004Max Planck School Matter to LifeMax Planck SocietyNIBIB NIH HHS ZIA-EB000094Research Council of Finland 321493Research Council of Finland 325464Research Council of Finland's Flagship InFLAMES 337530Research Council of Finland's Flagship InFLAMES 357910Sigrid Juselius FoundationSpanish Ministry for Science and Innovation MICCINN/FEDER ERDF-EUSpanish Ministry for Science and Innovation MICCINN/FEDER MCIN/AEI/10.13039/501100011033Spanish Ministry for Science and Innovation MICCINN/FEDER PID2021-128635NB-I00Volkswagen Foundation through the Initiative "Life?" Az.96733
6 · The paper itself

Abstract

Unjamming transitions from a solid-like to a fluid-like state are a gateway to breast epithelial cancer invasion. However, the mechanical interplay between phase transitions and dimension transitions, in particular wetting, remains elusive, despite being critical for understanding the onset of metastatic dissemination. This study shows that unjamming, mediated by the RAB5A GTPase, alters carcinoma spheroid fluidity, rigidity, and rewires adhesion mechanics to drive supracellular active wetting as a new mode of tumor expansion. Spheroid fluidification enhances the selective expression of integrin subunits and increases focal adhesion dynamics, inducing a fluid-like spreading behavior on specific matrix ligands. Notably, nanoscale regulation of integrin clustering can select for distinct phase transitions at the collective scale upon wetting. In this framework, fluidized spheroids polarize into cohesive "supracells", and maintain a stiff peripheral actin bundle as measured by nanomechanical mapping. Furthermore, a combination of Brillouin microscopy and 2.5D traction force analysis reveals a mechanical switch within the spheroid core, characterized by significant cell softening and a reduction in compressive forces exerted on the substrate, thereby mimicking the wetting of a liquid droplet. These findings establish unjamming-driven active wetting as a key mechanism to comprehend the molecular and biophysical underpinnings of solid tumor invasion.

Indexed as

Breast Neoplasmsrab5 GTP-Binding ProteinsSpheroids, CellularCell AdhesionCell Line, TumorFemaleHumansWettabilityRAB5C protein, humanrab5 GTP-Binding ProteinsadhesionbiophysicsmechanobiologyRAB5A‐mediated breast carcinoma fluidificationsofteningspheroid wettingsupracellular motility

Identifiers

PMID40712149
PMCPMC12442610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.